- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orexo AB (ORX)
Orexo AB stock price live, this page displays ST ORX stock exchange data. View the ORX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orexo AB real time stock price chart below.
What Is the Orexo AB Stock Price Today?
The Orexo AB stock price today is 21.1.
What Is the Stock Symbol for Orexo AB?
The stock symbol for Orexo AB is ""ORX.""
What Stock Exchange Does Orexo AB Trade On?
Orexo AB is listed and trades on the Stockholm stock exchange.
Is Orexo AB a Good Stock to Buy?
Determining whether Orexo AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORX quote. (ISIN: SE0000736415)
What Is the Orexo AB Stock Price Today?
The Orexo AB stock price today is 21.1.
What Is the Stock Symbol for Orexo AB?
The stock symbol for Orexo AB is ""ORX.""
What Stock Exchange Does Orexo AB Trade On?
Orexo AB is listed and trades on the Stockholm stock exchange.
Is Orexo AB a Good Stock to Buy?
Determining whether Orexo AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORX quote. (ISIN: SE0000736415)
21.1
-0.1(-0.24%)
Closed·
Fair Value
An estimate of a Orexo AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.5
21.8
52 wk Range
9.2
24.0
ORX Scorecard
Full Analysis
Impressive gross profit margins
ORX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Orexo AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.521.8
52 wk Range
9.224.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Orexo AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Orexo AB Company Profile
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Orexo AB Earnings Call Summary for Q2/2025
- Q2 revenue of 180M SEK beat forecast by 32.8%, driven by Subsol product; stock fell 6.17% despite beat
- Gross margin improved to 93%, but negative EBITDA of 10.1M SEK indicates ongoing financial challenges
- U.S. business EBIT strong at 31% margin; company maintains positive full-year EBITDA guidance
- Targeting Subsol net sales of $50-55M; focus on FDA approval for iCipri and expanding MorphoX platform
- CEO emphasized cost-conscious approach, confident in resolving ongoing investigations
Last Updated: 16/07/2025, 14:02
Read Full TranscriptCompare ORX to Peers and Sector
Metrics to compare | ORX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | 15.0x | −0.5x | |
PEG Ratio | 0.02 | 0.01 | 0.00 | |
Price/Book | −4.5x | 2.9x | 2.6x | |
Price / LTM Sales | 1.2x | 2.7x | 3.2x | |
Upside (Analyst Target) | 3.9% | 0.0% | 41.9% | |
Fair Value Upside | Unlock | 35.5% | 4.3% | Unlock |
Earnings
Latest Release
Jul 16, 2025
EPS / Forecast
-1.20 / -0.37
Revenue / Forecast
118.20M / 133.20M
FAQ
What Stock Exchange Does Orexo AB Trade On?
Orexo AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Orexo AB?
The stock symbol for Orexo AB is "ORX."
What Is the Orexo AB Market Cap?
As of today, Orexo AB market cap is 728.06M.
What Is Orexo AB's Earnings Per Share (TTM)?
The Orexo AB EPS (TTM) is -6.19.
When Is the Next Orexo AB Earnings Date?
Orexo AB will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is ORX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Orexo AB Stock Split?
Orexo AB has split 2 times.
How Many Employees Does Orexo AB Have?
Orexo AB has 110 employees.
What is the current trading status of Orexo AB (ORX)?
As of 24 Jul 2025, Orexo AB (ORX) is trading at a price of 21.10, with a previous close of 21.10. The stock has fluctuated within a day range of 20.50 to 21.80, while its 52-week range spans from 9.20 to 24.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.